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A tumour-associated cell-surface glycoprotein accompanying p53
overexpression and higher growth potential for gastric cancer
Y Maehara, T Okuyama, Y Kakeji, K Endo, M Yamamoto and K Sugimachi
Department ofSurgery II, Faculty ofMedicine. Kviushu University, Fukuoka 812. Japan.
S ary Tumour-associated cell-surface glycoprotein is associated with tumour progression in gastric
cancer. We investigated the biological significance of tumour-associated cell-surface glycoprotein, determined
by the binding of Helix pomatia agglutinin (HPA), with regrd to survival time and to the malignant potential
of cancer cells in serosally invasive gastric cancer in 119 patients. HPA was positively stained in 75 of 119
patients (63.0%) with gastric cancer with serosal invasion. In patients with HPA-positive tissue, the tumour
was larger than in HPA-negative cases and was frequently located in the middle third of the stomach. The
incidence of lymph node metastasis was higher than in patients with HPA-negative tissue. There were no
differences between the cases staining negatively and positively with HPA with respect to the other factors
eained. Gastric cancer tissues with HPA-positive staining revealed a higher positive rate of abnormal p53
staining and a higher concentration ofproliferating cell nuclear antigen (PCNA) labelling. The survival time of
the patients with HPA positive staining was shorter than for those whose tissues were HPA negative. Thus,
tumour-associated cell-surface glycoprotein is apparently closely related to the malignant potential of serosally
invasive gastnc cancer.
Keywords: gastric cancer; tumour-associated cell-surface glycoprotein; p53 overexpression; proliferating cell
nuclear antigen; prognosis
Lectins are proteins of plant or animal origin which bind
speifically to glycoconjugates. Using labelled lectin, car-
bohydrate residues in tissue sections can be detected using
histochemical procedures. This has led to a search for lectin
binding to detect carbohydrates related to tumour metastatic
behaviour (Schumacher et al., 1992), since cell-surface
glycoproteins have important roles in cell-to-cell interaction,
invasion and metastatic potential (Dennis et al., 1987; Buck-
ley and Carlsen, 1988; Olden, 1993). We have suggested that
binding sites for a lectin from the Roman snail, Helix
pomatia agglutinin (HPA), is a predictive marker of tumour
progression in gastric cancer (Kakeji et al., 1991a). HPA,
with a molecular mass of 79 kDa and a strong affinity for
N-acetyl-D-galactosamine and N-acetyl-i-glucosamine, spec-
ifically agglutinates human type A erythrocytes (Kawai et al.,
1991). In particular, the presence of lymph node metastasis is
related to HPA binding of gastric cancer cells. The intracel-
lular events linlked to these antigens expressed on the surface
of gastric cancer cells have remained unresolved.
At the level of the nucleus, abnormalities of tumour-
related genes and growth potential have been reported to
relate to the poor prognosis of the patient (Mori et al., 1993;
Uchino et al., 1993). The p53 gene is a tumour-suppressor
gene and p53 is a nuclear protein, a transcriptional activator
which regulates the onset of DNA replication at the GI-S
boundary (Vogelstein et al., 1992). The great majority of
mutations in the p53 gene are missense in type, leading to
production of full-length proteins with an altered conforma-
tion and abnormal biological properties (Hollstein et al.,
1991). Unlike the wild-type protein, which has a short half-
life, the great majority of tetramers containing mutant
protein are stable and therefore readily detectable by
immunochemistry using antibodies reactive to p53 (Kikuchi-
Yanoshita et al., 1992).
The primary aim of the present study was to determine
whether there was a relationship between the glycoproteins
and cell growth and, if so, what would be the effect on
biological aggressiveness of the cancer. Serosally invasive
gastric cancer has a variety of forms of recurrence and is
associated with a poorer prognosis than those with a lesser
degree of invasion. For such patients. we asked whether the
abnormality of cell-surface glycoproteins is associated with
the malignant potential and proliferating activity of the
cancer cells, determined by the concentration of proliferating
cell nuclear antigen (PCNA) labelling.
Patents and methods
This study included 119 unselected patients with primary
gastric cancer with serosal invasion, all of whom underwent
gastric resection in the Department of Surgery II, Kyushu
University, and affiliated hospitals in Fukuoka, Japan, from
1988 to 1991. All were examined clinically and pathologically
with respect to the factors given in Table I. Pathological
diagnosis and classification of the resected gastric cancer
tissues were made according to the General Rules for the
Gastric Cancer Study in Surgery and Pathology in Japan
(Japanese Research Society for Gastric Cancer, 1981, 1993;
Maehara et al., 1992). Gastric resection based on lymph node
dissection was classified as follows: DO, gastric resection,
including the incomplete removal of group 1 lymph nodes;
Dl, gastric resection, including the complete removal of
group 1 lymph nodes alone; D2, gastric resection including
the complete removal of group 1 and 2 lymph nodes; and
D3, gastric resection, including the complete removal of
group 1, 2 and 3 lymph nodes.
Tissue samples
Tissue samples for p53 staining with monoclonal antibody
PAB 240 were fixed in periodate-lysine-paraformaldehyde
(PLP) for 5 h immediately after surgical resection, embedded
in OTC compound (Miles, Elkart, IN, USA), embedding
medium for frozen tissue specimens, and preserved at - 80'C
(Kakeji et al., 1993). Sections 5 ym thick were cut on a
cryostat. For PCNA staining, paraffin blocks were prepared
as described by Mori et al. (1993).
Lectin histochemistry
Sections of 5 lm from paraffin blocks were dewaxed and
stained using the avidin-biotin-peroxidase complex (ABC)
method. Specifically, sections were incubated for 1 h with
HPA (10 Lg ml1-; Pharmacia, Sigma, St Louis, MO, USA) at
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Table I Clinicopathological factors (mean ± s.d.) in serosally invasive
gastric cancers with or without lymph node metastasis
HPA-negative HPA-positive
Factor (n =44) (n = 75) P-vahle
Age (years) 61.1 ± 11.9 60.4± 13.2 NS
Sex
Male
Female
Maximum tumour
diameter (cm)
Tumour location
Upper (C)
Middle (M)
Lower (A)
Histology
Differentiated
Undifferentiated
Specific'
Unknown'
Histological
growth pattern
Expansive
Intermediate
Infiltrative
Unknown'
Lymphatic involvement
No
Yes
Unknown'
Vascular involvement
No
Yes
Unknown'
Lymph node metastasis
No
Yes
Unknown'
Penrtoneal dissemination
No
Yes
Liver metastasis
No
Yes
Gastric resection
Partial
Total
Lymph node dissection.
DI
D2 and D3
Curability
Curable
Non-curable
25 (56.8%)
19 (43.2%)
8.20±4.08
15 (34.1%)
9 (20.5%)
20 (45.4%)
19 (45.2%)
23 (54.8%)
1
1
5 (11.4%)
18 (0.9%)
21 (47.7%)
0
9 (20.9%)
34 (79.1%)
1
19 (44.2%)
24 (55.8%)
1
12 (28.6%)
30 (71.4%)
2
49 (65.3%)
26 (34.7%)
9.58 ± 3.72
16 (21.3%)
36 (48.0%)
23 (30.7%)
34 (45.9%)
40 (54.1%)
1
0
6 (8.2%)
24 (32.9%)
43 (58.9%)
2
8 (10.7%)
67 (89.3%)
0
42 (59.2%)
29 (40.8%)
4
8 (11.0%)
65 (89.0%)
2
40 (90.9%) 65 (86.7%)
4 (9.1%) 10 (13.3%)
41 (93.2%) 65 (86.7%)
3 (6.8%) 10 (13.3%)
19 (43.2%) 30 (40.0%)
25 (56.8%) 45 (60.0%)
8 (18.2%) 15 (20.0%)
36 (81.8%) 60 (80.0%)
31 (70.5%) 50 (66.7%)
13 (29.5%) 25 (33.3%)
NS
NS, no significant difference. 'These cases were excluded from
statistical analysis.
room temperature before adding, sequentially, rabbit anti-
serum to HPA (1:10 for 1 h; Serotec, Oxford, UK) and
biotinylated goat anti-rabbit IgG (1:400 for 30 Bethesda
Research Laboratories, Gaithersburg, MD, USA) (Kakeji et
al., 1991a). The tissues were stained for 30min using ABC
kits (Vector Laboratories, Burlingame, CA, USA) and 3,3'-
diaminobenzidine/hydrogen peroxidase. Sections were coun-
terstained with Mayer's haematoxylin. using a microscopic
grid, the percentage of positively stained tumour cells was
calculated and graded according to the criteria of Kakeji et
al. (1991a), as follows: negative staining, 0-10%; positive
staining, more than 11%.
Immunohistochemical staining ofp53
PAb 240 is a mouse monoclonal antibody that recognises an
evolutionarily conserved epitope on p53; the epitope lies
between amino acids 156 and 214 on murine p53 (Gannon et
al., 1990). This antibody reacted with human, mouse, rat,
hamster, bovine and chicken p53 in Western immunoblotting
experiments. Sections of 5 glm were cut on a cryostat, dried
and washed in phosphate-buffered saline, pH 7.2 (PBS), then
incubated at room temperature with normal horse serum
(1:10 for 15m; Vector Laboratories). We then added PAb
240 (1:50 overnight; Oncogene Science, NY, USA), bio-
tinylated horse anti-mouse IgG (1:200 for 30mi; Vector
Laboratories) and the avidin-biotin-peroxidase complex
(for 30 min; Vector Laboratories). Peroxidase labelling was
developed with 3,3'-dia.minobenzidine and hydrogen perox-
idase and the sections were counterstained with haematoxy-
lin. We used KUPL40 as the positive control, a carcinoma
from a patient with familial polyposis coli transplanted into
nude mice and with a mutation in the p53 gene, as detected
by sequencing. Omission of the primary antibody served as
the negative control.
Proliferating cell nuclear antigen (PCNA) staining
Sections of 5 jim from paraffin blocks were dewaxed in
xylene, rehydrated through a series of ethanol and immersed
in 0.3% (v/v) hydrogen peroxide in methanol. These sections
were subsequently washed in PBS, and normal goat serum
was applied to reduce non-specific binding. The primary
antibody PC10, a monoclonal mouse antibody for rat
PCNA, was purchased from Dako (Denmark). The sections
were incubated for 2h with PC10 (dilution 1:20) at room
temperature, then with biotinylated goat anti-mouse IgG
(1:200 for 1 h), and finally with the avidin-biotin-
peroxidase complex (Mori et al., 1993). Peroxidase labelling
was developed with 3,3'-diaminobenzidine and hydrogen
peroxide, and the sections were counterstained with haema-
toxylin. All stained nuclei were scored as positive for PCNA.
The PCNA labelling index was determined by observing 1000
nuclei in areas of the section with the highest labelling fre-
quency, and the percentage of PCNA-labelled nuclei (PCNA
labelling index) was used for analysis.
Statistical analysis
The BMDP Statistical Package program (BMDP; Los
Angeles, CA, USA) for the IBM (Armonk, NY, USA) 4381
mainframe computer was used for all analyses (Dixon, 1988).
The BMDP P4F and P3S programs were used for the chi-
square test and the Mann-Whitney test to compare data on
patients between the groups. The BMDP PIL program was
used to analyse survival time by the Kaplan-Meier method
and the Mantel-Cox test was used to test for equality of the
survival curves. The accepted level of significance was
P<0.05.
Results
Clinicopathologicalfactors
HPA-positve cells showed either strong surface staining or, in
some cases, apical or diffuse cytoplasmic staining. In normal
tissue, positive staining with HPA was recognised in mucous
neck cells and in pyloric glands. HPA was also noted in the
basement membrane of small blood vessels in the cases
examined. In cancer tissues, positive HPA staining was dem-
onstrated in 75 (63.0%) of 119 primary tumours. No obvious
relation was found between HPA staining and the sex or age
of the patient (Table I). HPA-positive isolates were
associated with a larger tumour and location in the middle
third of the stomach and a higher incidence of metastasis to
lymph nodes (89.0%) than were HPA-negative cases (71.4%)
(P<0.05). The incidence of HPA staining was not related to
tumour histological type, lymphatic and venous invasion,
peritoneal dissemination, or liver metastasis for serosally
invasive gastnc cancer.
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Table H Relation between the grouping for HPA staining and p53
staining in gastric cancer tissues
Factor HPA-negative HPA-positive P-value
p53-negative 30 (76.9%) 18 (31.0%) P<0.01
p53-positive 9 (23.1%) 40 (69.0%)
Total 39 (100%) 58 (100%)
Table 111 Growth potential evaluated by PCNA labelling in gastric
cancer invading beyond the serosa
Factor HPA-negative HPA-positive P-value
(n=25) (n=51)
PCNA-labelling (%) 26.9 ± 12.3a 38.5 ± 10.2 P<0.01
aMean ± standard deviation.
Table IV Site ofrecurrence after resection for gastric cancer invading
beyond the serosa
Site ofrecurrence HPA-negative HPA-positive
Peritoneum 7 (38.9%) 20 (35.7%)
Liver 1 (5.6%) 6 (10.7%)
Lung 2 (11.1%) 4 (7.1%)
Bone 0 2 (3.6%)
Brain 1 (5.6%) 2 (3.6%)
Local 2 (11.1%) 6 (10.7%)
Lymph node 2 (11.1%) 5 (8.9%)
Unknown 5 (27.8%) 18 (32.1%)
Total 18 (100%) 56 (100%)
Relation between HPA andp53
We determined the relation between the HPA staining and
abnormal p53 staining. The positive rate for p53 was 23.1%
(9/39) in HPA-negative patients and 69.0% (40/58) in HPA-
positive patients, with a significant difference (P<0.01)
(Table II).
HPA staining andproliferating activity
The proliferating activity, expressed by PCNA labelling, was
significantly higher in tumour tissues with HPA-positive
staining than in those with HPA-negative staining, with a
significant difference (P<0.01) (Table III).
Recurrence pattern
The rate of recurrence was 40.9% (18/44) for HPA-negative
patients and 74.7% (56/75) for HPA-positive ones (Table
IV). Peritoneal and local recurrences were mainly noted in
HPA-negative patients, while there was a variety of forms of
recurrences, including peritoneal and distant organ recur-
rences in the HPA-positive patients.
Survival rate
The overall survival curve is shown in Figure 1, according to
HPA-negative or -positive staining. Patients with HPA-
positive cancers had a shorter survival time than did those
with HPA-negative cancers (P<0.01). The 5 year survival
rate was 54.4% for HPA-negative patients and 18.0% for
HPA-positive ones.
Cellular interactions and the rate of growth of cancer cells
seem to have an important role in the clinical behaviour of
tumours (Hakomori et al., 1989; Lampe et al., 1993). These
interactions are partly mediated by cell-surface glycoproteins
which are closely associated with the neoplastic transforma-
tion of cells (Altevogt et al., 1983; Pierce and Arango, 1986).
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Fugwe 1 Survival curves for patients with HPA negative and
HPA positive gastric cancer tissues. Patients with HPA-positive
tissues (thin line) had a poorer prognosis than those for HPA-
negative ones (thick line) (P<0.01).
Changes in cell-surface glycoproteins are thought to be
associated with altered cell adhesion and with the develop-
ment of invasive and metastatic properties in experimental
and human tumours (Dennis et al., 1987; Buckley and Carl-
sen, 1988; Dennis and Laferte, 1989; SeUl, 1990). Changes in
cell-surface carbohydrate occur during tumour progression,
and these changes can be detected by studying the binding
patterns of lectins (Hiraizumi et al., 1990). Positive staining
for HPA, which recognises N-acetyl-D-galactosamnine and N-
acetyl-E-glucosamine, was noted in cases of breast cancer to
be associated with metastasis to local lymph nodes and with
a higher recurrence and mortality rate (Fukutomi et al.,
1989). We have reported that the altered glycosylation of
cell-surface glycoprotein in gastric cancer, which was recog-
nised by HPA, is associated with lymph node metastasis and
a higher mortality rate, and we suggested that HPA staining
of the gastric cancer is closely related to the potential for
lymphatic spread of gastric cancer (Kakeji et al., 1991a).
These data prompted us to determine the molecular events
related to HPA-positive gastric cancers.
A close relation between HPA staining and amplification
of the c-myc gene or c-erbB-2 gene has been noted in human
breast cancer tissues (Fukutomi et al., 1991; Thomas et al.,
1993). In the present study, we clarified the correlations
between HPA staining of cancer cells, abnormality of the p53
gene and the prolferating activity determined by PCNA
labelling in gastric cancer. Carder et al. (1993) stated that
cells containing abnormal p53 protein are particularly at risk
of endoreduplication and hence of tetraploidy. Failure to
regulate p53 expression may lead to uncontrolled cell growth
(Lane, 1992; Livingstone et al., 1992; Yin et al., 1992). The
concentrations of PCNA, a highly conserved 36 kDa acidic
protein and auxiliary protein for DNA polymerase 6, which
is directly involved in DNA synthesis (Hall et al., 1990;
Waseem and Lane, 1990), correlate with the proliferative
state of cells and with the prognosis in gastric cancer (Mori
et al., 1993). PCNA labelling correlates with other para-
meters of cell proliferation (Ki-67 score, S-phase fraction, as
determined by flow cytometry, bromodeoxyuridine and
thymidine incorporations into DNA, and mitotic index) and
with DNA ploidy in human tumours (Hall et al., 1990;
Kakeji et al., 1991b). Thus, intracellular events related to p53
abnormality and detected by p53 protein staining are linked
to increased cellular proliferation and to the phenotype of
altered cell membrane glycoproteins. We have reported that
overexpression of p53 is closely related to the potential of
cancer cells to metastasise to lymph nodes in gastric cancer
(Kakeji et al., 1993). Joypaul et al. (1994) reported that p53
overexpression is an independent marker of a shorter survival
for gastric cancer patients. The p53 abnormality is likely to
accelerate the lymphatic spread of cancer cells through
association with altered cell membrane glycoproteins and a
poorer prognosis.
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The results of this study suggest that abnormalities in
cell-surface glycoproteims are closely linked to an abnormal
p53 gene and to a higher growth potential in gastric cancer.
These prognostic factors are assumed to be related to the
aggressiveness of gastric cancer. As tumours with high pro-
liferative activity are sensitive to anti-cancer drugs (Maehara
et al., 1990), HPA staining may aid in designing treatment
strategies for particular groups of patients.
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